microarray bead plate Search Results


96
Thermo Fisher 96 well plate
Flicr is expressed specifically in Tregs. Flicr expression in various contexts. (A and B) ImmGen mouse immunocyte (39) or GNF mouse organ microarray compendia (40) (dashed lines: background level). (C) During thymic Treg differentiation. (Left) ImmGen data. (Right) RNA-Seq analysis of CD4+ SP thymocytes sorted as shown; y-axis, transcripts per million (tpm). (D) Tissue Tregs. Each point is an individual mouse. Sp, spleen; Col, colonic lamina propria; Panc, pancreas; Adip. tissue, visceral adipose tissue; Muscle, injured muscle at 4 d postcardiotoxin injection. (E) After activation in vitro with <t>anti-CD3/CD28</t> beads (42) (Left) or in vivo (41) (Right). Rest., resting CD44loCD62Lhi; Act., activated CD44hiCD62Llo Tregs; rpkm, reads per kb per million reads. (F) In vitro converted induced Tregs (TCR activation with IL-2 and TGF-β) (43). (G) Ex vivo Helios−RORγ+ colonic peripheral Tregs (44). (H) In Tconvs transduced with Foxp3 or control retrovectors (11). (I) In Treg-like cells of mice with Foxp3 inactivation by Gfp insertion (Foxp3ΔGfp) (45).
96 Well Plate, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/96 well plate/product/Thermo Fisher
Average 96 stars, based on 1 article reviews
96 well plate - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier

90
Illumina Inc microarray bead plate
Flicr is expressed specifically in Tregs. Flicr expression in various contexts. (A and B) ImmGen mouse immunocyte (39) or GNF mouse organ microarray compendia (40) (dashed lines: background level). (C) During thymic Treg differentiation. (Left) ImmGen data. (Right) RNA-Seq analysis of CD4+ SP thymocytes sorted as shown; y-axis, transcripts per million (tpm). (D) Tissue Tregs. Each point is an individual mouse. Sp, spleen; Col, colonic lamina propria; Panc, pancreas; Adip. tissue, visceral adipose tissue; Muscle, injured muscle at 4 d postcardiotoxin injection. (E) After activation in vitro with <t>anti-CD3/CD28</t> beads (42) (Left) or in vivo (41) (Right). Rest., resting CD44loCD62Lhi; Act., activated CD44hiCD62Llo Tregs; rpkm, reads per kb per million reads. (F) In vitro converted induced Tregs (TCR activation with IL-2 and TGF-β) (43). (G) Ex vivo Helios−RORγ+ colonic peripheral Tregs (44). (H) In Tconvs transduced with Foxp3 or control retrovectors (11). (I) In Treg-like cells of mice with Foxp3 inactivation by Gfp insertion (Foxp3ΔGfp) (45).
Microarray Bead Plate, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microarray bead plate/product/Illumina Inc
Average 90 stars, based on 1 article reviews
microarray bead plate - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

99
Thermo Fisher dna template
A schematic representation of the RAPID-M technology. The modified T7Term primer was mixed with the immobilization beads in <t>a</t> <t>PCR</t> microwell plate ( a ) to create beads-immobilized T7Term primer ( b ). The target <t>DNA</t> is directly immobilized to the beads by PCR amplification using beads-immobilized T7Term and soluble <t>T7Prom</t> to create high density immobilized DNA (HDID) in each well ( c ). The beads-immobilized DNA is translated to protein with the addition of cell-free reagents ( d , e ) and the protein is arrayed onto Ni–NTA slides using a microarray printer to produce high density protein microarray slides (HDS) ( f )
Dna Template, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dna template/product/Thermo Fisher
Average 99 stars, based on 1 article reviews
dna template - by Bioz Stars, 2026-04
99/100 stars
  Buy from Supplier

Image Search Results


Flicr is expressed specifically in Tregs. Flicr expression in various contexts. (A and B) ImmGen mouse immunocyte (39) or GNF mouse organ microarray compendia (40) (dashed lines: background level). (C) During thymic Treg differentiation. (Left) ImmGen data. (Right) RNA-Seq analysis of CD4+ SP thymocytes sorted as shown; y-axis, transcripts per million (tpm). (D) Tissue Tregs. Each point is an individual mouse. Sp, spleen; Col, colonic lamina propria; Panc, pancreas; Adip. tissue, visceral adipose tissue; Muscle, injured muscle at 4 d postcardiotoxin injection. (E) After activation in vitro with anti-CD3/CD28 beads (42) (Left) or in vivo (41) (Right). Rest., resting CD44loCD62Lhi; Act., activated CD44hiCD62Llo Tregs; rpkm, reads per kb per million reads. (F) In vitro converted induced Tregs (TCR activation with IL-2 and TGF-β) (43). (G) Ex vivo Helios−RORγ+ colonic peripheral Tregs (44). (H) In Tconvs transduced with Foxp3 or control retrovectors (11). (I) In Treg-like cells of mice with Foxp3 inactivation by Gfp insertion (Foxp3ΔGfp) (45).

Journal: Proceedings of the National Academy of Sciences of the United States of America

Article Title: Flicr , a long noncoding RNA, modulates Foxp3 expression and autoimmunity

doi: 10.1073/pnas.1700946114

Figure Lengend Snippet: Flicr is expressed specifically in Tregs. Flicr expression in various contexts. (A and B) ImmGen mouse immunocyte (39) or GNF mouse organ microarray compendia (40) (dashed lines: background level). (C) During thymic Treg differentiation. (Left) ImmGen data. (Right) RNA-Seq analysis of CD4+ SP thymocytes sorted as shown; y-axis, transcripts per million (tpm). (D) Tissue Tregs. Each point is an individual mouse. Sp, spleen; Col, colonic lamina propria; Panc, pancreas; Adip. tissue, visceral adipose tissue; Muscle, injured muscle at 4 d postcardiotoxin injection. (E) After activation in vitro with anti-CD3/CD28 beads (42) (Left) or in vivo (41) (Right). Rest., resting CD44loCD62Lhi; Act., activated CD44hiCD62Llo Tregs; rpkm, reads per kb per million reads. (F) In vitro converted induced Tregs (TCR activation with IL-2 and TGF-β) (43). (G) Ex vivo Helios−RORγ+ colonic peripheral Tregs (44). (H) In Tconvs transduced with Foxp3 or control retrovectors (11). (I) In Treg-like cells of mice with Foxp3 inactivation by Gfp insertion (Foxp3ΔGfp) (45).

Article Snippet: Total CD4 T cells from spleen and subcutaneous lymph nodes were isolated by magnetic negative selection (Dynabeads Untouched Mouse CD4 T-Cell Kit, 11415D; Thermo Fisher Scientific) and activated in vitro in 200 µL of cRMPI for 72 h with anti-CD3/CD28 beads in a 96-well plate (0.1 M cell/well, 1:1 bead:cell ratio; Dynabeads Mouse T-Activator CD3/CD28; Thermo Fisher Scientific) and 50 U/mL IL-2 (recombinant human IL-2, 212–12; Peprotech).

Techniques: Expressing, Microarray, RNA Sequencing Assay, Injection, Activation Assay, In Vitro, In Vivo, Ex Vivo, Transduction

A schematic representation of the RAPID-M technology. The modified T7Term primer was mixed with the immobilization beads in a PCR microwell plate ( a ) to create beads-immobilized T7Term primer ( b ). The target DNA is directly immobilized to the beads by PCR amplification using beads-immobilized T7Term and soluble T7Prom to create high density immobilized DNA (HDID) in each well ( c ). The beads-immobilized DNA is translated to protein with the addition of cell-free reagents ( d , e ) and the protein is arrayed onto Ni–NTA slides using a microarray printer to produce high density protein microarray slides (HDS) ( f )

Journal: BMC Research Notes

Article Title: Development of repeatable arrays of proteins using immobilized DNA microplate (RAPID-M) technology

doi: 10.1186/s13104-015-1637-3

Figure Lengend Snippet: A schematic representation of the RAPID-M technology. The modified T7Term primer was mixed with the immobilization beads in a PCR microwell plate ( a ) to create beads-immobilized T7Term primer ( b ). The target DNA is directly immobilized to the beads by PCR amplification using beads-immobilized T7Term and soluble T7Prom to create high density immobilized DNA (HDID) in each well ( c ). The beads-immobilized DNA is translated to protein with the addition of cell-free reagents ( d , e ) and the protein is arrayed onto Ni–NTA slides using a microarray printer to produce high density protein microarray slides (HDS) ( f )

Article Snippet: Standard PCR conditions were: 100–150 ng DNA template (pIVEX2.3d-GFP or ompA linearized template, 1 mM MgSO 4 , 1X PCR buffer, 0.3 mM dNTP mix, 0.8 pmol T7Prom soluble primer, 5 μg beads-immobilized primer and 1.25 U Platinum pfx DNA polymerase (Invitrogen) in a final reaction volume of 10 μl.

Techniques: Modification, Amplification, Microarray

Western blot analysis of GFP ( a ) and OmpA ( b ) proteins using beads-immobilized DNA template. Proteins were detected using peroxidase-conjugated anti-polyHistidine monoclonal antibody. The calculated protein sizes for GFP and OmpA are 30 and 27 kDa, respectively. DNA templates used for cell-free expression were as follows: a Lane 1 , gfp -SA beads template; lane 2 , gfp -CA beads template; lane 3 , soluble DNA coding for GFP (as positive control); lane 4 , no DNA template (as negative control). b Lane 1 , no DNA template (as negative control); lane 2 , ompA -CA beads template; lane 3 , ompA -SA beads template; lane 4 , soluble ompA protein coding DNA (as positive control)

Journal: BMC Research Notes

Article Title: Development of repeatable arrays of proteins using immobilized DNA microplate (RAPID-M) technology

doi: 10.1186/s13104-015-1637-3

Figure Lengend Snippet: Western blot analysis of GFP ( a ) and OmpA ( b ) proteins using beads-immobilized DNA template. Proteins were detected using peroxidase-conjugated anti-polyHistidine monoclonal antibody. The calculated protein sizes for GFP and OmpA are 30 and 27 kDa, respectively. DNA templates used for cell-free expression were as follows: a Lane 1 , gfp -SA beads template; lane 2 , gfp -CA beads template; lane 3 , soluble DNA coding for GFP (as positive control); lane 4 , no DNA template (as negative control). b Lane 1 , no DNA template (as negative control); lane 2 , ompA -CA beads template; lane 3 , ompA -SA beads template; lane 4 , soluble ompA protein coding DNA (as positive control)

Article Snippet: Standard PCR conditions were: 100–150 ng DNA template (pIVEX2.3d-GFP or ompA linearized template, 1 mM MgSO 4 , 1X PCR buffer, 0.3 mM dNTP mix, 0.8 pmol T7Prom soluble primer, 5 μg beads-immobilized primer and 1.25 U Platinum pfx DNA polymerase (Invitrogen) in a final reaction volume of 10 μl.

Techniques: Western Blot, Expressing, Positive Control, Negative Control

Repetitive cell-free expression of GFP and OmpA proteins using immobilized DNA templates. a Lane 1 , GFP from soluble DNA (as positive control); lanes 2–5 , GFP protein from the first, second, third and fourth sequential rounds of cell-free expression using gfp -CA beads template; lanes 6-9 , GFP protein from the first, second, third and fourth sequential rounds of cell-free expression using gfp -SA beads template; lane 10 , no DNA template (as negative control). b Lanes 1–4 , OmpA protein from the first, second, third and fourth sequential rounds of cell-free expression using ompA -CA beads template; lane 5 , OmpA protein from soluble DNA (as positive control); lane 6 , no DNA template (as negative control)

Journal: BMC Research Notes

Article Title: Development of repeatable arrays of proteins using immobilized DNA microplate (RAPID-M) technology

doi: 10.1186/s13104-015-1637-3

Figure Lengend Snippet: Repetitive cell-free expression of GFP and OmpA proteins using immobilized DNA templates. a Lane 1 , GFP from soluble DNA (as positive control); lanes 2–5 , GFP protein from the first, second, third and fourth sequential rounds of cell-free expression using gfp -CA beads template; lanes 6-9 , GFP protein from the first, second, third and fourth sequential rounds of cell-free expression using gfp -SA beads template; lane 10 , no DNA template (as negative control). b Lanes 1–4 , OmpA protein from the first, second, third and fourth sequential rounds of cell-free expression using ompA -CA beads template; lane 5 , OmpA protein from soluble DNA (as positive control); lane 6 , no DNA template (as negative control)

Article Snippet: Standard PCR conditions were: 100–150 ng DNA template (pIVEX2.3d-GFP or ompA linearized template, 1 mM MgSO 4 , 1X PCR buffer, 0.3 mM dNTP mix, 0.8 pmol T7Prom soluble primer, 5 μg beads-immobilized primer and 1.25 U Platinum pfx DNA polymerase (Invitrogen) in a final reaction volume of 10 μl.

Techniques: Expressing, Positive Control, Negative Control

Application of the RAPID-M method for generation of protein arrays. The proteins were printed using the Nano-Plotter™ NP 2.1. Immobilized proteins were in situ purified on Ni–NTA chip and subjected to detection using peroxidase-conjugated anti-polyHistidine antibody followed by addition of TSA-Cy5. Lane 1–4 , proteins from repetitive cycles of first, second, third and fourth rounds of cell-free expression using immobilized DNA template. Proteins are printed in 3 × 3 blocks and each block represents one cycle of cell-free expression using beads-immobilized DNA

Journal: BMC Research Notes

Article Title: Development of repeatable arrays of proteins using immobilized DNA microplate (RAPID-M) technology

doi: 10.1186/s13104-015-1637-3

Figure Lengend Snippet: Application of the RAPID-M method for generation of protein arrays. The proteins were printed using the Nano-Plotter™ NP 2.1. Immobilized proteins were in situ purified on Ni–NTA chip and subjected to detection using peroxidase-conjugated anti-polyHistidine antibody followed by addition of TSA-Cy5. Lane 1–4 , proteins from repetitive cycles of first, second, third and fourth rounds of cell-free expression using immobilized DNA template. Proteins are printed in 3 × 3 blocks and each block represents one cycle of cell-free expression using beads-immobilized DNA

Article Snippet: Standard PCR conditions were: 100–150 ng DNA template (pIVEX2.3d-GFP or ompA linearized template, 1 mM MgSO 4 , 1X PCR buffer, 0.3 mM dNTP mix, 0.8 pmol T7Prom soluble primer, 5 μg beads-immobilized primer and 1.25 U Platinum pfx DNA polymerase (Invitrogen) in a final reaction volume of 10 μl.

Techniques: In Situ, Purification, Expressing, Blocking Assay